HIV treatment stops the HIV replication that causes immune damage. But there are places in the body where the virus "hides" ...

Is the cost of research aimed at curing HIV worth it, when HIV can be effectively managed and prevented by existing drugs?

Nearly 40 million individuals globally are currently living with HIV, a virus that has resulted in the loss of over 42 ...

A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One ...

But the Trump administration’s cuts to HIV programs in the U.S. and abroad could undermine the drug’s rollout.

Strategy may lead to new ... effective in preventing HIV. Strategy may lead to new vaccines that only need to be taken once. Vishwam Sankaran. Thursday 19 June 2025 12:03 BST. Comments. FDA ...

Pharmaceutical company Gilead Sciences announced Wednesday the Food and Drug Administration (FDA) has approved its six-month, twice-yearly HIV PrEP injection, which was found in trials to be more ...

The new HIV PrEP option could drastically reduce the number of new cases by offering a new alternative to daily pills or ...

Pharmaceutical company Gilead Sciences announced Wednesday the Food and Drug Administration (FDA) has approved its six-month, twice-yearly HIV PrEP injection, which was found in trials to be more ...

Learning the best type of HIV prevention for those at highest risk can start with conversations about their options, writes ...

Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...

The 'Silence=Death' poster from the early years of the AIDS crisis holds true today with the possibility of federal cuts to ...